Published Online: July 30, 2014. doi:10.1001/jamadermatol.2014.605.
Study concept and design: Payne, Rader, Dyer, Stoecker.
Acquisition, analysis, or interpretation of data: Payne, Schilli, Meier, Rader, Mold, Green, Stoecker.
Drafting of the manuscript: Payne, Rader, Stoecker.
Critical revision of the manuscript for important intellectual content: Payne, Schilli, Meier, Rader, Dyer, Mold, Green, Stoecker.
Statistical analysis: Payne, Schilli, Meier, Stoecker.
Obtained funding: Stoecker.
Administrative, technical, or material support: Green, Stoecker.
Study supervision: Stoecker.
Conflict of Interest Disclosures: Drs Green and Stoecker are coholders of a patent on an ELISA BRS envenomation test. Dr Stoecker is founder and CEO of SpiderTek, manufacturer of spider tests and traps. Mss Payne, Schilli, and Meier and Mr Rader are employees of SpiderTek.
Funding/Support: This study was supported in part by SpiderTek and made possible by phase 1 and 2 awards R43 AR055863-01 and R44 AR055863-02 from the National Institutes of Health.
Role of the Sponsor: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of NIH.
Additional Contributions: We appreciate the cooperation of those who volunteered to be included in this study. Participants received no compensation for their involvement.